GADOVIST 604.72 mg/ml 7.5 mLl
Description
GADOVIST 604.72 mg/ml 7.5 ml INJECTABLE SOLUTION
Composition:
Each ml of solution for injection contains Gadobutrol 604.72 mg, equivalent to Gadobutrol 1.0 mmol.
Therapeutic Action:
Diagnostic adjuvant agents.
Administration:
Gadovist is given by intravenous injection.
Indications:
Magnetic resonance imaging (MRI) contrast medium used to diagnose the brain, spine, and blood vessels.
Gadovist can also help the doctor find out the type of known or suspected abnormalities (benign or malignant) in the liver and kidneys. Gadovist can also be used for MRI of abnormalities in other parts of the body. It facilitates the visualization of abnormal structures or lesions and aids in the differentiation of healthy tissue and diseased tissue. It is indicated in adults and children of all ages (including term neonates).
Posology:
According to medical criteria by age, body weight, and the region examined by MRI.
Warning:
Do not administer during pregnancy or when its existence is suspected, or during lactation, unless the risk/benefit balance is favorable according to medical criteria. If its use is essential, definitely discontinue breastfeeding.
Caution:
Hepatic and/or kidney failure, Heart or circulatory failure.
Symptomatic cerebrovascular diseases, recent cerebrovascular accident, transient ischemic attacks, intracranial tumors or metastases, acute demyelination, cerebral edema, and other conditions that present with damage to the blood-brain barrier, multiple myeloma, paraproteinemia, gout, pheochromocytoma, pre-existing autoimmune disorder, myasthenia gravis.
Patients older than 60 years.
Presentation:
Box of 7.5 ml vial
Storage:
Do not store above 30 °C.
Manufacturer:
Bayer.
Reviews
There are no reviews yet.